Risk of solid tumors and myeloid hematological malignancies among first-degree relatives of patients with monoclonal gammopathy of undetermined significance.

Abstract

1. Jonsson S, Olsson B, Ohlsson C, Lorentzon M, Mellström D, Wadenvik H. Increased cortical bone mineralization in imatinib treated patients with chronic myelogenous leukemia. Haematologica 2008;93:1101-3. 2. Millot F, Guilhot J, Nelken B, Leblanc T, De Bont E, Bekassy AN, et al. Imatinib mesylate is effective in children with chronic myelogenous leukemia… (More)
DOI: 10.3324/haematol.2009.006346

Topics

2 Figures and Tables

Cite this paper

@article{Kristinsson2009RiskOS, title={Risk of solid tumors and myeloid hematological malignancies among first-degree relatives of patients with monoclonal gammopathy of undetermined significance.}, author={Sigurdur Yngvi Kristinsson and Lynn R. Goldin and Magnus Bj{\"{o}rkholm and Ingemar Turesson and Ola Landgren}, journal={Haematologica}, year={2009}, volume={94 8}, pages={1179-81} }